Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
247.90
-8.62 (-3.36%)
Aug 11, 2026, 12:04 PM EDT - Market open
Jazz Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,601 | 4,268 | 4,069 | 3,834 | 3,659 | 3,094 | |
Revenue Growth | 12.59% | 4.88% | 6.12% | 4.78% | 18.26% | 30.91% |
Cost of Revenue | 532.91 | 503.3 | 445.71 | 435.58 | 540.52 | 440.76 |
Gross Profit | 4,068 | 3,764 | 3,623 | 3,399 | 3,119 | 2,653 |
Selling, General & Admin | 1,679 | 1,809 | 1,385 | 1,343 | 1,417 | 1,452 |
Depreciation & Amortization Expenses | 680.41 | 654.66 | 627.31 | 608.28 | 599.17 | 525.77 |
Research & Development | 815.61 | 782.74 | 884 | 849.66 | 590.45 | 505.75 |
Other Operating Expenses | 242.26 | 947.86 | 10 | 19 | 577.8 | - |
Total Operating Expenses | 3,417 | 4,195 | 2,907 | 2,820 | 3,184 | 2,483 |
Operating Income | 896.84 | -430.24 | 716.63 | 578.58 | -65.53 | 170.28 |
Interest Expense | -170.98 | -195.05 | -238.1 | -289.44 | -288.24 | -278.77 |
Other Non-Operating Income (Expense) | 1.84 | -2.57 | -8.18 | 8.79 | -19.01 | -4.35 |
Total Non-Operating Income (Expense) | -169.14 | -197.62 | -246.28 | -280.65 | -307.26 | -283.12 |
Pretax Income | 727.71 | -627.86 | 470.35 | 297.93 | -372.78 | -112.84 |
Provision for Income Taxes | -213.26 | -272.44 | -91.43 | -119.91 | -158.65 | 216.12 |
Net Income | 940.97 | -355.42 | 561.78 | 417.84 | -214.14 | -328.95 |
Minority Interest in Earnings | 0.2 | 0.73 | 1.66 | 3.01 | 9.92 | 0.71 |
Net Income to Common | 940.76 | -356.15 | 560.12 | 414.83 | -224.06 | -329.67 |
Net Income Growth | - | - | 35.02% | - | - | - |
Shares Outstanding (Basic) | 62 | 61 | 62 | 63 | 63 | 60 |
Shares Outstanding (Diluted) | 65 | 61 | 66 | 72 | 63 | 60 |
Shares Change | 5.53% | -7.61% | -8.41% | 15.23% | 4.77% | 5.62% |
EPS (Basic) | 15.25 | -5.84 | 9.06 | 6.55 | -3.58 | -5.52 |
EPS (Diluted) | 14.50 | -5.84 | 8.65 | 6.10 | -3.58 | -5.52 |
EPS Growth | - | - | 41.80% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,591 | 1,297 | 1,358 | 1,068 | 1,243 | 750.87 |
Free Cash Flow Growth | 25.79% | -4.48% | 27.13% | -14.07% | 65.53% | -15.12% |
Free Cash Flow Per Share | 24.43 | 21.27 | 20.57 | 14.82 | 19.87 | 12.58 |
Gross Margin | 88.42% | 88.21% | 89.05% | 88.64% | 85.23% | 85.76% |
Operating Margin | 19.49% | -10.08% | 17.61% | 15.09% | -1.79% | 5.50% |
Profit Margin | 20.45% | -8.33% | 13.81% | 10.90% | -5.85% | -10.63% |
FCF Margin | 34.58% | 30.39% | 33.37% | 27.86% | 33.97% | 24.27% |
EBITDA | 1,615 | 266.06 | 1,377 | 1,217 | 563.94 | 722.76 |
EBITDA Margin | 35.10% | 6.23% | 33.83% | 31.75% | 15.41% | 23.36% |
EBIT | 896.84 | -430.24 | 716.63 | 578.58 | -65.53 | 170.28 |
EBIT Margin | 19.49% | -10.08% | 17.61% | 15.09% | -1.79% | 5.50% |
Effective Tax Rate | -29.31% | 43.39% | -19.44% | -40.25% | 42.56% | -191.53% |